Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Jason Lettmann

CEO at Alx Oncology Holdings Inc (ALXO)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $31K

Reported trades

Filed Stock Type Shares Price Value Since
Aug 18SEC ALXOAlx Oncology Holdings Inc Sell 2,230294,379 held (−1%) $1.93 $4K -45.1%
Mar 23SEC ALXOAlx Oncology Holdings Inc Sell 12,311293,609 held (−4%) $2.17 $27K -51.2%